Involvement of PI3K/Akt Pathway in Prostate Cancer - Potential Strategies for Developing Targeted Therapies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|5|12|1125-1132

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.5, Iss.12, 2005-12, pp. : 1125-1132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

By  

Current Cancer Drug Targets, Vol. 9, Iss. 2, 2009-03 ,pp. : 237-249

Bentham Science Publishers

Access to resources Recommend Favorite

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

By  

Current Cancer Drug Targets, Vol. 8, Iss. 3, 2008-05 ,pp. : 187-198

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 12, 2010-04 ,pp. : 1410-1416

Bentham Science Publishers

Access to resources Recommend Favorite

Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer

By  

Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. : 245-251

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 36-62

Bentham Science Publishers

Access to resources Recommend Favorite